Delivery Order SPE2DB25D3003-SPE2DB25FPVKX

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $39K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVKX
    Delivery Order

This federal contract award is for the procurement of KISQALI 600 MG DAILY DOSE 63S, a specialty pharmaceutical product, by the Defense Logistics Agency (DLA) Troop Support Medical. The $39,332.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov).

The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is one of multiple contract awards to Amerisourcebergen from federal agencies, including the Department of Justice Federal Bureau of Investigation, demonstrating the company's role as a key vendor for critical medical commodities across the federal government.

Generated 3/19/25, 9:47 AM